Latest Payments News

Western Yilgarn NL has reported a maiden discovery of high-grade gallium-tellurium mineralisation at its Ida Holmes Junction Project, alongside confirmation of extensive cobalt-nickel-copper-lead-scandium mineralisation continuity. The company also updated its substantial bauxite resource base in its March 2026 quarterly report.

Finico Pty Ltd, already holding 57.5% of DTI Group, has launched an on-market takeover offer for all remaining shares at 1.2 cents each, representing a 20% premium over the last close. The offer opens 29 April and closes 29 May 2026, with Shaw and Partners appointed to facilitate the purchases.

InFocus Group Holdings has launched Codexa, a proprietary sweepstakes casino platform targeting the US market, and secured an expanded contract for its Prodigy9 subsidiary in Thailand, while navigating cash flow pressures amid ongoing R&D investment.

Scalare Partners (ASX:SCP) reported a striking 771% year-on-year revenue increase to $5.26 million in Q3 FY26, alongside positive operating cashflow of $2.84 million, driven by ecosystem growth and new partnerships.

Venari Minerals has delivered a maiden JORC Inferred Mineral Resource Estimate for its Red Mountain Lithium Project in Nevada, revealing 3.03 million tonnes of contained Lithium Carbonate Equivalent. The company also reported improved beneficiation results and completed a share buyback to streamline its register.

Gullewa Limited progresses with Hunter Valley property construction, submits a critical mining lease extension for South Darlot, and boosts its Central Iron Ore stake through a rights issue.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.

Katana Capital Limited has declared a fully franked quarterly dividend of 0.5 cents per share for the March 2026 quarter, with the dividend reinvestment plan price set at AUD 1.361271.

Invex Therapeutics reported promising preclinical findings on Exenatide’s effects in a human Alzheimer's disease model, alongside a steady cash position and reduced operating outflows in Q3 FY26.

Eastern Resources (ASX:EFE) has activated the farm-in period for its Marengo Gold Project, marking a key milestone with fieldwork planned after Queensland’s wet season. The company maintains steady cash reserves and advances environmental assessments at its Nowa Nowa Iron Project.

Energy Resources of Australia (ERA) advances rehabilitation at its Ranger site while awaiting a Federal Court decision on Rio Tinto’s compulsory acquisition bid. Seasonal conditions and higher rainfall have delayed critical Pit 3 capping trials, with financial reserves remaining strong despite no production activity.

Rokeby Resources (ASX:RKB) has secured the Omeo Gold Project in Victoria, adding a historical resource of 320,000 ounces at 4.0 g/t Au and launching a $4 million capital raise. The acquisition ushers in leadership changes and sets a clear path for resource expansion.